How Tumor-Infiltrating Lymphocytes Attach to Blood Vessels
Author Information
Author(s): DH Adams, JR Yannelli, W Newman, T Lawley, E Ades, SA Rosenberg, S Shaw
Primary Institution: University of Birmingham; National Cancer Institute; Emory University School of Medicine; Center for Disease Control and Prevention
Hypothesis
The study investigates how tumor-infiltrating lymphocytes (TILs) bind to tumor endothelium and the implications for their migration to tumors.
Conclusion
TILs show enhanced binding to endothelium, which may affect their ability to migrate to tumors effectively.
Supporting Evidence
- TILs showed higher levels of integrins and adhesion molecules compared to peripheral blood T cells.
- TILs bound more effectively to both resting and activated endothelial cells.
- Manipulation of TIL culture conditions could enhance their tumor-homing capabilities.
Takeaway
The study looks at how special immune cells called TILs stick to blood vessels, which helps them get to tumors. Understanding this can help make cancer treatments better.
Methodology
The study involved analyzing the cell-surface phenotype and endothelial binding of TILs cultured from human melanoma and comparing them with peripheral blood T cells and allostimulated T cells.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo behavior.
Participant Demographics
TILs were prepared from seven patients with malignant melanoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website